𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Smell identification test as an indicator for cognitive impairment in Alzheimer's disease

✍ Scribed by Y. Suzuki; S. Yamamoto; H. Umegaki; J. Onishi; N. Mogi; H. Fujishiro; A. Iguchi


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
99 KB
Volume
19
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objectives

The aim of the present study was to assess olfactory dysfunction in patients with Alzheimer's disease (AD) and to compare utility of the olfactory tests as possible clinical markers.

Methods

Two olfactory identification tests (The Cross‐Cultural Smell Identification Test [CC‐SIT] and the Picture‐based Smell Identification Test [P‐SIT]) and the Mini Mental State Examination (MMSE) were administered to patients with AD and age‐matched controls. Apolipoprotein E (Apo E) genotypes of patients with AD were identified.

Results

Patients with AD had significantly lower olfactory identification scores than age‐matched non‐demented elderly subjects in both olfactory assessments. In the AD group, the coefficient of correlation between the MMSE scores and the P‐SIT scores was higher than that between the MMSE scores and the CC‐SIT scores. Receiver operating curve (ROC) analyses for both tests indicated that the P‐SIT discriminated AD patients from controls more reliably than did the CC‐SIT. Within AD patients, those who were carrying one or two ApoE ε4 alleles had a higher coefficient of correlation between the MMSE scores and the P‐SIT scores than patients without the ApoE ε4 allele.

Conclusions

The results suggest that a short and simple non‐lexical olfactory identification test can be useful as a clinical marker of AD appropriate for Japanese elderly population. Copyright © 2004 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Neural correlates of anosognosia for cog
✍ Eric Salmon; Daniela Perani; Karl Herholz; Patricia Marique; Elke Kalbe; Vjera H 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

## Abstract We explored the neural substrate of anosognosia for cognitive impairment in Alzheimer's disease (AD). Two hundred nine patients with mild to moderate dementia and their caregivers assessed patients' cognitive impairment by answering a structured questionnaire. Subjects rated 13 cognitiv

Use of the Brief Smell Identification Te
✍ Grete Kjelvik; Sigrid Botne Sando; Jan Aasly; Knut A. Engedal; Linda R. White 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract ## Aims Several studies have shown that Alzheimer's disease (AD) is associated with hyposmia. Olfactory identification may be a cheap and simple additional test in the assessment of early cognitive changes. The sense of smell is influenced by factors such as experience and culture and

Cognitive and functional neuroimaging co
✍ Asmus Vogel; Steen G. Hasselbalch; Anders Gade; Morten Ziebell; Gunhild Waldemar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract ## Objectives To investigate the correlation between anosognosia and behavioural symptoms, performance on executive tests, and frontal cortex regional cerebral blood flow (rCBF) in patients with ‘amnestic mild cognitive impairment’ (MCI) and mild Alzheimer's disease (AD). ## Methods

Anosognosia for memory deficit in amnest
✍ Filomena Galeone; Stella Pappalardo; Sergio Chieffi; Alessandro Iavarone; Sergio 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract ## Objective to investigate patterns of anosognosia for memory deficit in subjects with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). ## Methods the study involved twenty‐five subjects with MCI, 15 with mild AD and 21 normal controls (NC). Subjective rating o

Verbal cued recall as a predictor of con
✍ E. Dierckx; S. Engelborghs; R. De Raedt; M. Van Buggenhout; P. P. De Deyn; D. Ve 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Abstract ## Objective This study was set up to investigate whether neuropsychological tests are able to predict conversion to AD among Mild Cognitive Impairment (MCI) patients. ## Methods At baseline the cognitive part of the Cambridge Examination for Mental Disorders of the Elderly (CAMCOG),

The montreal cognitive assessment as a s
✍ David J. Gill; Arielle Freshman; Jennifer A. Blender; Bernard Ravina 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysf